Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2003 3
2004 4
2005 4
2006 2
2007 4
2008 8
2009 9
2010 7
2011 10
2012 5
2013 16
2014 14
2015 14
2016 9
2017 10
2018 19
2019 22
2020 12
2021 17
2022 14
2023 10
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group.
Koziolek M, Alcaro S, Augustijns P, Basit AW, Grimm M, Hens B, Hoad CL, Jedamzik P, Madla CM, Maliepaard M, Marciani L, Maruca A, Parrott N, Pávek P, Porter CJH, Reppas C, van Riet-Nales D, Rubbens J, Statelova M, Trevaskis NL, Valentová K, Vertzoni M, Čepo DV, Corsetti M. Koziolek M, et al. Eur J Pharm Sci. 2019 Jun 15;134:31-59. doi: 10.1016/j.ejps.2019.04.003. Epub 2019 Apr 8. Eur J Pharm Sci. 2019. PMID: 30974173 Free article. Review.
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial.
Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, Dreier RF, Sassi-Sayadi M, Haskell LP, Narkiewicz K, Wang JG; PRECISION investigators. Schlaich MP, et al. Lancet. 2022 Dec 3;400(10367):1927-1937. doi: 10.1016/S0140-6736(22)02034-7. Epub 2022 Nov 7. Lancet. 2022. PMID: 36356632 Clinical Trial.
Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: An UNGAP review.
Vertzoni M, Augustijns P, Grimm M, Koziolek M, Lemmens G, Parrott N, Pentafragka C, Reppas C, Rubbens J, Van Den Αbeele J, Vanuytsel T, Weitschies W, Wilson CG. Vertzoni M, et al. Among authors: koziolek m. Eur J Pharm Sci. 2019 Jun 15;134:153-175. doi: 10.1016/j.ejps.2019.04.013. Epub 2019 Apr 13. Eur J Pharm Sci. 2019. PMID: 30991092 Free article. Review.
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome.
Gross O, Tönshoff B, Weber LT, Pape L, Latta K, Fehrenbach H, Lange-Sperandio B, Zappel H, Hoyer P, Staude H, König S, John U, Gellermann J, Hoppe B, Galiano M, Hoecker B, Ehren R, Lerch C, Kashtan CE, Harden M, Boeckhaus J, Friede T; German Pediatric Nephrology (GPN) Study Group and EARLY PRO-TECT Alport Investigators. Gross O, et al. Kidney Int. 2020 Jun;97(6):1275-1286. doi: 10.1016/j.kint.2019.12.015. Epub 2020 Jan 17. Kidney Int. 2020. PMID: 32299679 Free article. Clinical Trial.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators. Baigent C, et al. Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12. Lancet. 2011. PMID: 21663949 Free PMC article. Clinical Trial.
Assessment of food effects during clinical development.
Vinarov Z, Butler J, Kesisoglou F, Koziolek M, Augustijns P. Vinarov Z, et al. Among authors: koziolek m. Int J Pharm. 2023 Mar 25;635:122758. doi: 10.1016/j.ijpharm.2023.122758. Epub 2023 Feb 18. Int J Pharm. 2023. PMID: 36801481 Review.
Immunoadsorption in steroid-refractory multiple sclerosis.
Koziolek MJ, Kitze B, Mühlhausen J, Müller GA. Koziolek MJ, et al. Atheroscler Suppl. 2013 Jan;14(1):175-8. doi: 10.1016/j.atherosclerosissup.2012.10.026. Atheroscler Suppl. 2013. PMID: 23357161 Review.
[Acute kidney injury: from creatinine to KIM‑1?].
Wallbach M, Tampe B, Dihazi H, Koziolek MJ. Wallbach M, et al. Among authors: koziolek mj. Internist (Berl). 2019 Jun;60(6):578-586. doi: 10.1007/s00108-019-0602-y. Internist (Berl). 2019. PMID: 31001671 Review. German.
Apheresis in treatment of acute inflammatory demyelinating disorders.
Mühlhausen J, Kitze B, Huppke P, Müller GA, Koziolek MJ. Mühlhausen J, et al. Among authors: koziolek mj. Atheroscler Suppl. 2015 May;18:251-6. doi: 10.1016/j.atherosclerosissup.2015.02.037. Atheroscler Suppl. 2015. PMID: 25936333 Review.
Challenges in Permeability Assessment for Oral Drug Product Development.
Koziolek M, Augustijns P, Berger C, Cristofoletti R, Dahlgren D, Keemink J, Matsson P, McCartney F, Metzger M, Mezler M, Niessen J, Polli JE, Vertzoni M, Weitschies W, Dressman J. Koziolek M, et al. Pharmaceutics. 2023 Sep 28;15(10):2397. doi: 10.3390/pharmaceutics15102397. Pharmaceutics. 2023. PMID: 37896157 Free PMC article. Review.
185 results